PCR (qPCR, dPCR, Singleplex, Multiplex) Market Research Report 2025-2030 with Situation Analysis, Executives and Marketing Guide, & Investment Analysts and Management Consultants Guide
Explore the evolving PCR technology landscape with our comprehensive report. Discover market trends, including Singleplex and Multiplex testing, and the impact of digital PCR. Uncover investment opportunities in Point of Care Testing and Molecular Diagnostics. Gain insights with five-year forecasts and expert analysis.
Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "PCR Markets: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place Forecasting and Analysis" has been added to ResearchAndMarkets.com's offering.
This report provides comprehensive insights into how this convergence will shape future market dynamics, presenting critical information for industry stakeholders.
The global landscape of disease diagnosis is undergoing a significant transformation, with PCR technology at its forefront. While the pandemic elevated PCR to a dominant position, ushering in a digital revolution within the sector, new markets and technologies are now emerging that may redefine diagnostics. This transition presents both opportunities and challenges for stakeholders.
A newly released report offers an in-depth analysis of the market, featuring a five-year forecast that is uniquely segmented into Singleplex and Multiplex testing markets. PCR, which has showcased remarkable adaptability, gained widespread recognition as an essential tool in diagnostics. The advent of digital PCR further promises to enhance its efficacy, offering reduced costs and improved patient outcomes. Moreover, digital PCR stands as a powerful contender in combating Anti Microbial Resistance.
For professionals seeking to leverage this data, the report is an indispensable resource that can transform executives into industry experts. It enables informed investment decisions and accurate company valuations, backed by the most current data available. With its detailed five-year market forecasts, the report equips organizations with the tools needed to strategically navigate this evolving landscape.
In a market driven by innovation, understanding the nuances of these emerging technologies and their implications is crucial. This report encapsulates the trends, challenges, and opportunities that define the future of PCR technologies and diagnostics. Stay ahead of the curve by accessing the latest findings that will keep PCR at the core of disease detection and management globally.
Discover how emerging diagnostics technology and market innovations are reshaping the competitive landscape. Access the full report today to explore untapped potential and prepare for the future of healthcare.
Key Topics Covered:
1 Market Guides1.1 Situation Analysis1.2 Guide for Executives and Marketing Staff1.3 Guide for Investment Analysts and Management Consultants
2 Introduction and Market Definition2.1 What are PCR Technologies?2.2 PCR and Syndromic Testing2.3 Market Definition2.4 Methodology2.5 Perspective: Healthcare and the IVD Industry2.5.1 Global Healthcare Spending2.5.2 Spending on Diagnostics2.5.3 Important Role of Insurance for Diagnostics
3 PCR - Guide to PCR Technologies3.1 Concepts3.1.1 Method3.2 Applications3.2.1 Finding Specific DNA3.2.2 Measuring DNA3.2.3 Medical and Diagnostic Applications3.2.3.1 Carrier, prenatal and tissue typing3.2.3.2 Cancer Diagnosis and Management3.2.3.3 Infectious Disease - New Levels of Accuracy and Sensitivity3.2.3.4 Forensic Applications3.2.3.5 Science and Research3.3 PCR - Advantages and Disadvantages3.4 Different Types of PCR3.4.1 Simple Changes3.4.1.1 Multiplex-PCR3.4.1.2 VNTR PCR3.4.1.3 Asymmetric PCR3.4.1.4 Long PCR3.4.1.5 Nested PCR3.4.1.6 Quantitative PCR3.4.1.7 Hot-start PCR3.4.1.8 Touchdown PCR3.4.1.9 Assembly PCR3.4.1.10 Colony PCR3.4.1.11 Suicide PCR3.4.1.12 Cold PCR3.4.2 Digital PCR3.4.2.1 Droplet Digital PCR3.4.2.2 Comparison between dPCR and Real-Time PCR (qPCR)3.4.2.3 Digital PCR in Use3.4.2.4 Digital PCR Commercial History3.4.3 Isothermal PCR
4 Industry Overview4.1 Players in a Dynamic Market4.1.1 Academic Research Lab4.1.2 Diagnostic Test Developer4.1.3 Instrumentation Supplier4.1.4 Chemical/Reagent Supplier4.1.5 Pathology Supplier4.1.6 Independent Clinical Laboratory4.1.7 Public National/regional Laboratory4.1.8 Hospital Laboratory4.1.9 Physicians Office Lab (POLS)4.1.10 Audit Body4.1.11 Certification Body
5 Market Trends5.1 Factors Driving Growth5.1.1 A New Standard5.1.2 Down the Curve We Go5.1.3 Multiplexing5.1.4 Syndromic Diagnostics Looks Unstoppable5.1.5 The Genetic Blizzard5.2 Factors Limiting Growth5.2.1 The Cost Curve5.2.2 The Other Guys5.2.3 Systemic Roadblocks5.3 Diagnostic Technology Development5.3.1 The Instrumentation Curve5.3.2 Shifting Role of Diagnostics5.3.3 Diagnostics Moves Out of the Hospital5.3.4 Disruption Looms5.3.5 The Next Five Years
6 PCR Recent Developments6.1 Recent Developments - Importance and How to Use This Section6.1.1 Importance of These Developments6.1.2 How to Use This Section6.2 Seegene, Microsoft Collaborate for MDx Development6.3 QuidelOrtho Expanding Savanna Test Menu6.4 Binx Health Refocuses on POC STI Testing6.5 Qiagen, Myriad Genetics Partner to Develop Cancer Dx6.6 VedaBio Detecting Nucleic Acid With CRISPR6.7 Evvy Launches Add-on STI Screen6.8 ChromaCode Shifts to Oncology with dPCR Lung Cancer Test6.9 Multiplex Meningitis/Encephalitis Panel Market Expanding6.10 Sensible Dx to Launch 10-Minute POC PCR System6.11 ReadyGo Dx Plans to Make MDx Testing Easy6.12 Transformative Biotech Acquires Summit Biolabs' PCR Tech6.13 Visby Medical POC STI Multiplex Test Cleared6.14 Sherlock Biosciences Buys Sense Biodetection6.15 Agilent, Qiagen Nab FDA Approvals for Lung Cancer Treatment CDx6.16 HealthTrackRx Investing in Rapid Turnaround Times6.17 LEX Dx Developing Ultra-Fast Low-Cost PCR6.18 Next-Gen Dx Technologies Face Uncertain Future6.19 Rover Dx Developing All-Optical Rapid POC qPCR Platform6.20 ProtonDx Plans Rapid Molecular Dx Instrument6.21 Innova Medical Group Licenses MDx Tech6.22 MicroGEM to Grow Market for 30-Minute RT-PCR System6.23 Precipio Receives CE-IVD Mark for Cancer Panels6.24 Siemens Healthineers to Develop Next-Gen MDx Platform6.25 New York State Approves Enzo Biochem HPV Molecular Test6.26 Grip Molecular Developing Biosensor Panel to Detect Respiratory Infections6.27 Co-Diagnostics Seeks EUA for At-Home PCR Diagnostic System6.28 Chelex-Based Protocol to Reduce Cost, Time for PCR Testing6.29 Finnish Firms to Form Point-of-Care Testing Firm6.30 Visby Medical Scales Up Handheld PCR Test for STIs6.31 DnaNudge Raises $60M6.32 Roche Reports Diagnostics Revenue Up 51 Percent6.33 BforCure Preparing Multiple ID Panels for PoC qPCR Platform6.34 Enzo Biochem, CLX Health Partner for C19 Testing for Travel6.35 Bio Molecular Systems Gets Approval for Portable PCR Cycler6.36 Roche Acquires GenMark6.37 Handheld qPCR Devices Close to Commercialization6.38 Nuclein Closes $14M in Funding6.39 WuXi Diagnostics Closes $150M Series B Financing Round6.40 Visby Medical to develop rapid Flu-COVID PCR test6.41 Thermo Fisher to Acquire Mesa Biotech
7 Profiles of Key PCR Companies7.1 Abbott Laboratories7.2 Accelerate Diagnostics7.3 Ador Diagnostics7.4 ADT Biotech7.5 Agilent7.6 Akonni Biosystems7.7 Altona Diagnostics7.8 Alveo Technologies7.9 Amoy Diagnostics Co., Ltd.7.10 Anatolia Geneworks7.11 Applied BioCode7.12 Applied DNA Sciences7.13 Aurora Biomed7.14 Aus Diagnostics7.15 AVIVA Systems Biology7.16 Beckman Coulter Diagnostics (Danaher)7.17 Becton, Dickinson and Company7.18 Binx Health7.19 Biocartis7.20 bioMerieux Diagnostics7.21 Bioneer Corporation7.22 Bio-Rad Laboratories, Inc7.23 Bosch Healthcare Solutions GmbH7.24 Bruker7.25 Caris Molecular Diagnostics7.26 Cepheid (Danaher)7.27 Credo Diagnostics Biomedical7.28 CTK Biotech7.29 Cue Health7.30 Curetis (OpGen)7.31 Diagenode Diagnostics (Hologic)7.32 Diasorin S.p.A.7.33 Eiken Chemical7.34 Enzo Biochem7.35 Eurofins Scientific7.36 Fluxergy7.37 Fujirebio7.38 Genetic Signatures7.39 GenMark Dx (Roche)7.40 Greiner Bio-One7.41 Hologic7.42 Immunexpress7.43 Inflammatix7.44 Invetech7.45 J&J Innovative Medicine7.46 Karius7.47 LumiraDx7.48 Maxim Biomedical7.49 Meridian Bioscience7.50 Millipore Sigma7.51 Molbio Diagnostics7.52 Nanomix7.53 NGeneBio7.54 Novacyt7.55 Nuclein7.56 Operon7.57 Panagene7.58 Precipio7.59 Primerdesign (Novacyt)7.60 Promega7.61 Prominex7.62 Qiagen7.63 QuantuMDx7.64 QuidelOrtho7.65 Randox Toxicology7.66 R-Biopharm AG7.67 Revvity7.68 Roche Diagnostics7.69 Scope Fluidics7.70 SD Biosensor7.71 Seegene7.72 Siemens Healthineers7.73 SkylineDx7.74 Sona Nanotech7.75 SpeeDx7.76 Standard BioTools7.77 Stilla Technologies7.78 Streamline Scientific7.79 T2 Biosystems7.80 Thermo Fisher Scientific7.81 Uniogen7.82 Vela Diagnostics7.83 Veramarx7.84 Veredus Laboratories7.85 Vircell7.86 Visby Medical7.87 XCR Diagnostics7.88 YD Diagnostics7.89 Zhejiang Orient Gene Biotech
8 The Global PCR Markets8.1 PCR - Global Market Overview by Country8.2 Global Market by Application - Overview8.3 Global Market by Technology - Overview8.4 Global Market by Product - Overview8.5 Global Market by Place - Overview
9 Global PCR Markets - By Application9.1 PCR Clinical Multiplex9.2 PCR Clinical Singleplex9.3 PCR Research
10 Global PCR Markets - By Technology10.1 qPCR10.2 dPCR
11 Global PCR Markets - By Product11.1 PCR Instruments11.2 PCR Nucleic Acid Extraction11.3 PCR Consumables11.4 PCR Services
12 Global PCR Markets - By Place12.1 PCR Clinical Laboratory12.2 PCR Point of Care12.3 PCR Commercial12.4 PCR Pharmaceutical
13 Appendices13.1 Growth of Approved IVD Test Menu13.2 Growth of Approved Average IVD Test Fee13.3 The Most Used IVD Assays13.4 The Highest Grossing Assays13.5 Laboratory Fees Schedule
For more information about this report visit https://www.researchandmarkets.com/r/xdrygn
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Poundland moves to new ownership under Gordon Brothers
Pepco Group has finalised the sale of its Poundland business to Gordon Brothers International LLC, marking a significant step in the company's strategy to focus on its higher margin Pepco retail operations. The transaction, completed in June 2025, is expected to simplify Pepco Group's structure and enhance overall profitability. The sale of Poundland, a UK-based discount retailer operating over 800 stores and employing around 16,000 people, aligns with Pepco Group's decision to concentrate on its core Pepco brand, which primarily offers clothing and general merchandise. In the previous financial year, Poundland accounted for about one-third of group revenues but contributed only 5% to earnings before interest, tax, depreciation, and amortisation (EBITDA). The divestment is designed to improve revenue growth, increase margins, and boost cash generation by focusing on the more profitable Pepco operations across Europe. Gordon Brothers is a global advisory, restructuring, and investment firm that specialises in helping businesses with asset management, turnaround, and growth strategies. Established over a century ago, the company works across various industries to manage and revitalise brands and operations. Their acquisition of Poundland fits within their wider approach to investing in retail businesses and supporting their development. Poundland was sold for nominal consideration, with Pepco retaining secured and unsecured loans amounting to £30 million as part of the deal. A restructuring plan involving the transfer of certain financial arrangements is pending approval by the High Court in England. Under the new ownership, Poundland will continue to operate under its established brand in the UK, led by current managing director Barry Williams. Pepco Group expects to retain a minority investment interest, allowing it to maintain some involvement in Poundland's future performance. Both companies have also agreed on transitional service arrangements to support operations during the changeover. This move is part of a broader strategy by Pepco Group to streamline its portfolio and focus on sectors delivering higher returns and stronger growth prospects, moving away from fast-moving consumer goods (FMCG) and potentially considering further divestments in related businesses. Several news outlets, including the BBC, have reported that Poundland was sold for approximately £1. However, Pepco's official statement did not disclose a specific sale price, instead referring only to the shares being sold for "nominal consideration," which typically means a very small or symbolic amount. "Poundland moves to new ownership under Gordon Brothers" was originally created and published by Retail Insight Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
20 minutes ago
- Yahoo
Temenos named best-selling core banking provider for 20th consecutive year by IBS Intelligence
Temenos ranked #1 in 13 categories in the IBSi Sales League table, including core, digital, payments and wealth GRAND-LANCY, Switzerland, June 13, 2025 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), a global leader in banking technology, today announced it has been recognized as the #1 best-selling software provider in 13 categories in the IBSi Sales League Table (SLT) 2025. Temenos ranked #1 for core banking for the 20th consecutive year, while also topping the table for categories covering digital, payments, wealth and Islamic banking. The results highlight the breadth of Temenos' leadership as the banking technology provider of choice across multiple product segments. The IBS Intelligence Annual Sales League Table is an annual benchmarking exercise, which is now in its 24th year and is based on the number of new customer contracts signed in a calendar year. The SLT is recognized as the barometer for financial technology providers' sales performance across the banking industry. Jean-Pierre Brulard, CEO, Temenos, said: 'I'm delighted to see Temenos top the rankings in 13 different categories in the IBSi Sales League Table, highlighting the strength and breadth of our market-leading capabilities. Being named the number one core banking software provider globally for 20 years in a row reflects both our customer-centric focus and relentless investment in innovation. As we continue to lead banking forward with the launch of game-changing Generative and Agentic AI capabilities, the advanced functionality, agility and scalability of our solutions makes Temenos a compelling choice for banks of all sizes around the world.' Temenos ranked #1 In the IBSi SLT 2025 across the following 13 categories: Universal Banking – Core Digital Banking and Channels Payments – Retail Private Banking and Wealth Management Risk Management Treasury and Risk Management Digital Only Banks Datawarehouse & BI Islamic Banking – Universal Banking – Core Islamic Banking – Risk Management Islamic Banking – Payments – Retail Islamic Banking – Wholesale Banking Treasury Islamic Banking – Digital Banking and Channels With its market-leading core banking suite and best-in-class modular solutions, Temenos offers financial institutions choice, flexibility and a proven path to banking modernization – underpinned with cloud-native architecture, and embedded AI. Trusted by over 950 core banking clients and over 650 digital clients around the world, Temenos software can be deployed on-premises, in the cloud, or as SaaS. Investing around 20% of revenues in R&D, Temenos continues to enhance its capabilities. Recent innovations include the launch of a Gen AI Copilot to help financial institutions design, launch, test and optimize financial products faster, as well as an FCM AI Agent that can help banks significantly reduce false positives in sanctions screening. Nikhil Gokhale, Director – Research & Digital Properties at IBS Intelligence, commented: 'The 2025 edition of the IBSi Sales League Table reflects the growing maturity of digital transformation across the global banking industry. With sustained investment in modern core platforms, intelligent digital channels, and real-time payments, banks are clearly prioritizing agility, scale, and customer experience. Temenos has once again demonstrated exceptional global leadership, with standout performance in Core, Digital, Payments, and Risk. On behalf of IBSi, I extend my congratulations to the Temenos team for consistently being at the forefront of innovation and execution. The SLT continues to serve as a trusted benchmark for momentum in banking technology worldwide.' Recognition in the IBSi SLT is the latest industry accolade for Temenos, which was also named a Leader in the 2024 IDC MarketScapes for Digital Core Banking Platforms in North America, EMEA and Asia Pacific and in the Forrester Wave™: Digital Banking Processing Platforms, Q4 2024. CONTACT: Scott Rowe Temenos + 44 (0) 20 7423 3857 in to access your portfolio
Yahoo
25 minutes ago
- Yahoo
Global Peristaltic Pumps Market to Reach $2.38 Billion by 2030: Increasing Demand for Contamination-Free Fluid Handling
The global peristaltic pumps market is forecasted to grow to USD 2.38 billion in 2030, with a CAGR of 3.9%. This growth is driven by rising demand for contamination-free fluid handling across industries like pharmaceuticals, food & beverages, and water treatment. The Middle East & Africa region, with ongoing industrial developments, is the second-fastest-growing market. Key players including Watson-Marlow and Verder Group are analyzed in this comprehensive industry report. Peristaltic Pumps Market Dublin, June 13, 2025 (GLOBE NEWSWIRE) -- The "Peristaltic Pumps Market by Type, Flow Rate, End-use Industry and Region - Global Forecast to 2030" has been added to peristaltic pumps market is projected to grow from USD 1.97 billion in 2025 to USD 2.38 billion in 2030, registering a CAGR of 3.9%. This growth is driven by the escalating need for contamination-free fluid handling across pharmaceuticals, food & beverage, and water treatment industries where gentle, precise, and hygienic pumping actions are essential. Hose pumps: A rapidly growing segment Peristaltic hose pumps, known for handling highly viscous, abrasive, and corrosive fluids, are gaining traction as the second-fastest-growing segment. Their robust performance in industrial sectors such as chemical processing, construction, and mining, coupled with low maintenance and high longevity, makes them indispensable in heavy-duty applications. The demand is further propelled by infrastructure projects and industrial automation needs, necessitating reliable fluid handling systems. High-flow pumps on the rise The segment with flow rates above 2000 mL/min is the second-fastest-growing, driven by industries such as mining and water treatment that require efficient handling of large fluid volumes. These pumps excel at providing smooth flow with minimal shear, particularly in challenging conditions, thus fulfilling the need for continuous high-volume operations. Food & Beverages: Key growth sector The food & beverage sector is another rapidly expanding segment due to the demand for hygienic, contamination-free operations. Peristaltic pumps' ability to move sensitive and shear-sensitive fluids like sauces and juices without product damage is crucial, aligning with stringent sanitary regulations and demand for processed foods. Middle East & Africa: Emerging market region The Middle East & Africa are witnessing significant market growth fueled by heavy investments in industrialization and environmental initiatives like Saudi Arabia's Vision 2030. Increased efforts in water treatment and regional manufacturing are boosting the demand for advanced fluid handling solutions, including peristaltic pumps. The report covers key players like Watson-Marlow Fluid Technology Solutions (UK), Verder Group (Netherlands), ProMinent Group (Germany), Cole-Parmer Instrument Company, LLC (US), Valmet (Finland), Graco Inc. (US), among others, providing a competitive analysis of their market positions and strategic developments. Comprehensive research coverage The research report offers categorization based on type, flow rate, end-use industry, and regional analysis, providing key insights into market drivers, restraints, opportunities, and challenges. It includes a detailed competitive analysis of major market players and forecasts opportunities for market entrants. Reasons to purchase the report: Understand the competitive landscape and gain insights for business positioning and strategy planning. Analyze key market drivers like wastewater treatment regulations and pharmaceuticals expansion. Explore opportunities in smart technologies and market diversifications. Evaluate innovative product launches and geographic market potentials. Assess market shares and growth strategies of industry leaders like Watson-Marlow, Verder Group, and others. Key Attributes: Report Attribute Details No. of Pages 265 Forecast Period 2025 - 2030 Estimated Market Value (USD) in 2025 $1.97 Billion Forecasted Market Value (USD) by 2030 $2.38 Billion Compound Annual Growth Rate 3.9% Regions Covered Global Key Topics Covered: Market Dynamics Drivers Stringent regulations for wastewater treatment and increasing capacity additions. Increasing global investments in new water and wastewater treatment facilities. Expansion of pharmaceutical production globally. Adoption of single-use technologies in bioprocessing. Rising food and beverage processing. Restraints Availability of large numbers of alternatives. Fluctuations in raw material prices. Opportunities Smart technologies in peristaltic pumps. Rising capacity expansions and joint venture initiatives by end-users in fast-growing markets. Small/miniature peristaltic pumps. Growing agriculture and renewable energy sectors. Challenges Growing demand for customization from end-use industries. Low scope for product differentiation. Frequent hose or tube replacements. Case Studies Energy and maintenance cost reduction with Flexflo M3 peristaltic pumps at Lompoc City Water Treatment Plant. Upgrading lime dosing system with Verderflex Dura 65 hose pumps in manufacturing food. Application of peristaltic pumps in detergent dispensing in fully automatic washing machines. Company Profiles Watson-Marlow Fluid Technology Solutions Verder Group Prominent Group Cole-Parmer Instrument Company, LLC Valmet Graco Inc. Wanner Engineering, Inc. Randolph Austin Company Idex Heidolph Scientific Products GmbH Gilson Incorporated Ravel Hiteks Pvt. Ltd Psg Seko S.P.A. Tapflo Group Aalborg Integra Biosciences Etatron Ragazzini Srl Welco Co. Ltd. Changzhou Prefluid Technology Co. Ltd. Lead Fluid (Baoding) Intelligent Equipment Manufacturing Co. Ltd. Kamoer Fluid Tech (Shanghai) Co. Ltd. Electrolab India Pvt. Ltd. Technomed (India) Private Limited Pumpsquare Systems Llp For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Peristaltic Pumps Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
